ABCC1 and chronic myelogenous leukemia, BCR-ABL1 positive: Recently, a genome-wide CRISPR/Cas9 screen in the human chronic myeloid leukemia cell line K562 identified ABCC1, SLC30A1, and AQP3 as important regulators of arsenic toxicity (Sobh et al, 2019).